Detalhe da pesquisa
1.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
N Engl J Med
; 377(9): 839-848, 2017 08 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-28854085
2.
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke.
Circulation
; 138(25): 2884-2894, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30566004
3.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
N Engl J Med
; 377(22): 2197-2198, 2017 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-29171823
4.
Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.
Hum Mol Genet
; 20(16): 3289-303, 2011 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21596841
5.
Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial.
Diabetes Care
; 43(7): 1546-1552, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32366578
6.
Occurence of First and Recurrent Major Adverse Cardiovascular Events With Liraglutide Treatment Among Patients With Type 2 Diabetes and High Risk of Cardiovascular Events: A Post Hoc Analysis of a Randomized Clinical Trial.
JAMA Cardiol
; 4(12): 1214-1220, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31721979
7.
Liraglutide and Glycaemic Outcomes in the LEADER Trial.
Diabetes Ther
; 9(6): 2383-2392, 2018 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-30392095
8.
Amylase, Lipase, and Acute Pancreatitis in People With Type 2 Diabetes Treated With Liraglutide: Results From the LEADER Randomized Trial.
Diabetes Care
; 40(7): 966-972, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476871
9.
The link between benign prostatic hyperplasia and prostate cancer.
Nat Rev Urol
; 10(1): 49-54, 2013 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23165396
10.
Long-term prostate-specific antigen velocity in improved classification of prostate cancer risk and mortality.
Eur Urol
; 64(3): 384-93, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23398767
11.
Prostate-specific antigen and long-term prediction of prostate cancer incidence and mortality in the general population.
Eur Urol
; 61(5): 865-74, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22104593
12.
Association of clinical benign prostate hyperplasia with prostate cancer incidence and mortality revisited: a nationwide cohort study of 3,009,258 men.
Eur Urol
; 60(4): 691-8, 2011 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-21705134
13.
Reply from Authors re: Andrew J. Vickers, Michael J. Pencina. Prostate-specific antigen velocity: new methods, same results, still no evidence of clinical utility. Eur Urol 2013;64:394-6: prostate-specific antigen velocity: new unscreened cohort, natural history of prostate cancer, room for different interpretations.
Eur Urol
; 64(3): 396-7, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23571004